EUVIMEDEUVIMED entdecken
Crossref

Combination of SIX4-siRNA and temozolomide inhibits the growth and migration of A-172 glioblastoma cancer cells

Zahra Jodari Mohammadpour, Reza Mohammadzadeh, Darya Javadrashid, Amir Baghbanzadeh, Mohammad Amin Doustvandi, Nesa Barpour, Behzad Baradaran

Naunyn-Schmiedeberg's Archives of Pharmacology · 2023

DOI: 10.1007/s00210-023-02495-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2023. Verfasst von Zahra Jodari Mohammadpour und 6 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHumansTemozolomideRNA, Small InterferingDacarbazineCell ProliferationCell Line, TumorApoptosisAntineoplastic Agents, AlkylatingDrug Resistance, NeoplasmTrans-ActivatorsHomeodomain Proteins

Stichwörter der Autor:innen

A-172 cell lineCombination therapyGlioblastomaSIX4-siRNATemozolomide

Substanzen

TemozolomideRNA, Small InterferingDacarbazineAntineoplastic Agents, AlkylatingSIX4 protein, humanTrans-ActivatorsHomeodomain Proteins

Autor:innen und Institutionen

  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Faculty of Basic Sciences, Department of Biology, University of Maragheh, Maragheh, Iran.
  • Faculty of Basic Sciences, Department of Biology, University of Maragheh, Maragheh, Iran. rmohamadzadeh82@gmail.com.
  • Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. behzad_im@yahoo.com.

Zitieren

APA

Mohammadpour, Z. J., Mohammadzadeh, R., Javadrashid, D., Baghbanzadeh, A., Doustvandi, M. A., Barpour, N., & Baradaran, B. (2023). Combination of SIX4-siRNA and temozolomide inhibits the growth and migration of A-172 glioblastoma cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-023-02495-5

Vancouver

Mohammadpour ZJ, Mohammadzadeh R, Javadrashid D, Baghbanzadeh A, Doustvandi MA, Barpour N, et al. Combination of SIX4-siRNA and temozolomide inhibits the growth and migration of A-172 glioblastoma cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 2023. doi:10.1007/s00210-023-02495-5

BibTeX
@article{Mohammadpour2023,
  author = {Mohammadpour, Zahra Jodari and Mohammadzadeh, Reza and Javadrashid, Darya and Baghbanzadeh, Amir and Doustvandi, Mohammad Amin and Barpour, Nesa and Baradaran, Behzad},
  title = {Combination of SIX4-siRNA and temozolomide inhibits the growth and migration of A-172 glioblastoma cancer cells},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2023},
  doi = {10.1007/s00210-023-02495-5}
}
Kostenlos starten →